Type 1 diabetes trials in United States

In United States 216 Also abroad 537

216 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
Permissive Versus Strict Intrapartum Glucose Management in Type 1 and Type 2 Diabetes (PRISM)
Where
Columbus
Age
18 years and over
People
44
Run by
Ohio State University
See details and how to joinNCT07293715
No phaseTaking people
Long-Term Outcomes of Teplizumab in Routine Clinical Care
Where
Atlanta, New York, Sandy City, Syosset, Washington D.C.
People
1,000 worldwide
Run by
Sanofi
See details and how to joinNCT07360080
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Where
Beltsville, Champaign, Chicago, Columbus, Escondido, Fargo, Franklin, Houston, Jacksonville, Kansas City, Las Vegas, Lincoln, Manassas, Oxon Hill, Portland, Renton, Smithfield, Somerset, Statesville, Stockbridge, Walnut Creek, Woodstock
Age
18 years and over
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00
No phaseNot yet taking people in United States
Inter-Arm Differences in Continuous Glucose Monitor Readings in Adults With Diabetes
Where
Stockton
Age
18 years and over
People
60
Run by
University of the Pacific
See details and how to joinNCT07920341
Phase 3Not yet taking people in United States
CKM For Safe Use of SGLT2i in Type 1 Diabetes
Where
La Jolla
Age
18 years and over
People
52
Run by
University of California, San Diego
See details and how to joinNCT07211802
Phase 3Taking people
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Where
Charlottesville, Iowa City, Louisville, Philadelphia, Santa Barbara, Tallahassee, West Des Moines
Age
1 year to 35 years
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00
Phase 3Taking people
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Where
Aurora, Charlottesville, Corpus Christi, Philadelphia, Tallahassee
Age
1 year to 35 years
People
300 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00
No phaseTaking people
C-Carbs: A CGM-guided Approach to Teaching Carb Awareness
Where
Los Angeles
Age
18 years and over
People
40
Run by
University of California, Los Angeles
See details and how to joinNCT07807280
No phaseNot yet taking people in United States
Relationship Between Insulin Dose and Complications in Type 1 Diabetes
Where
Pittsburgh
People
80
Run by
Rachel Miller
See details and how to joinNCT07911033
No phaseTaking people
Closed Loop and Education for Hypoglycemia Awareness Restoration
Where
La Jolla, Lexington, Minneapolis, Orlando, Philadelphia
Age
18 years to 75 years
People
324 worldwide
Run by
Milton S. Hershey Medical Center
See details and how to joinNCT06325202
No phaseTaking people
Supporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language Training Initiative
Where
Aurora
Age
10 years to 20 years
People
15
Run by
University of Colorado, Denver
See details and how to joinNCT07720388
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Ames, Arlington, Bridgeport, Butte, Champaign, Chicago, Clearwater, Columbus, Cortland, Dothan, El Dorado, Escondido, Fargo, Houston, Huntsville, Jacksonville, Jefferson City, Jersey City, Kansas City, Kingsport, Las Vegas, Maumee, Memphis, Mesa, Owensboro, Philadelphia, Portland, Renton, Rochester, Rocky Mount, Salt Lake City, San Antonio, Seattle, Smithfield, Statesville, Stockbridge, Sugar Land, Troy, Tulsa, Waco, Wilmington
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
No phaseTaking people
Starting Technology in At Risk Type 1 Diabetes Study
Where
Santa Monica, Sylmar, Torrance
Age
18 years and over
People
40
Run by
University of California, Los Angeles
See details and how to joinNCT06453928
No phaseNot yet taking people in United States
Care COMPASS Study
Where
Portland
Age
18 years and over
People
200
Run by
Fitbit LLC
See details and how to joinNCT07904793
No phaseTaking people
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Where
Sioux Falls
People
20,000
Run by
Sanford Health
See details and how to joinNCT01793168
Phase 4Taking people
Cholesterol Lowering and Residual Risk in Diabetes, Type 1
Where
New York
Age
18 years to 89 years
People
125
Run by
NYU Langone Health
See details and how to joinNCT05641753
No phaseTaking people
T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes
Where
New Haven
Age
18 years to 40 years
People
114
Run by
Yale University
See details and how to joinNCT07059806
No phaseEnrolling by invitation
Multicenter Assessment of the Pancreas in Type 1 Diabetes
Where
Aurora, Austin, Chicago, Nashville
Age
8 years and over
People
250 worldwide
Run by
Vanderbilt University Medical Center
See details and how to joinNCT03585153
Phase 2Not yet taking people in United States
Mitigating DKA in Type 1 Diabetes for Safe Use of SGLT Inhibitors Using Dual Continuous Ketone and Glucose Monitoring.
Where
Minneapolis
Age
18 years to 75 years
People
80
Run by
HealthPartners Institute
See details and how to joinNCT07325201
No phaseTaking people
Sleep Coach for Adolescents With Type 1 Diabetes
Where
Nashville
Age
11 years to 17 years
People
150
Run by
Vanderbilt University Medical Center
See details and how to joinNCT06516614
Phase 1/2Taking people
Denosumab for Type 1 Diabetes
Where
Birmingham, Duarte, Indianapolis
Age
18 years to 50 years
People
45
Run by
City of Hope Medical Center
See details and how to joinNCT06524960
Phase 1Taking people
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
Where
Boston, Chapel Hill, Duarte, Durham, Gainesville, Miami, New York, San Diego, San Francisco
Age
18 years to 55 years
People
16
Run by
GentiBio, Inc
See details and how to joinNCT06919354
No phaseTaking people
Cardiometabolic Effects of Non-Nutritive Sweeteners (NNS) in Type 1 Diabetes (T1D)
Where
Milwaukee
Age
15 years to 24 years
People
20
Run by
Medical College of Wisconsin
See details and how to joinNCT07434544
No phaseTaking people
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
Where
Atlanta, Aurora, Austin, Charlottesville, Chula Vista, Gainesville, Idaho Falls, New Haven, Palo Alto, Renton, San Antonio, San Diego, San Francisco, Santa Barbara, Seattle, Tampa, Walnut Creek
Age
2 years to 80 years
People
1,500
Run by
Medtronic MiniMed, Inc.
See details and how to joinNCT07864168
Phase 1Not yet taking people in United States
A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 Diabetes
Where
Anaheim, Columbus, Dallas, Daytona Beach, Decatur, Los Alamitos, Marlton, Miami, San Antonio, Walnut Creek, Winter Park
Age
18 years to 65 years
People
617 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881887